Innomar Strategies in the news

Biocon has partnered with Innomar Strategies to strengthen its pharmaceutical supply chain and distribution network across Canada.

CNX Therapeutics entered a distribution agreement with Innomar Strategies for Sativex in Canada.

Cencora, Inc. and Innomar Strategies Inc. amended their credit agreement, increasing their multi-currency revolving credit facility to $7.0 billion and extending its maturity, alongside adjusting their receivables securitization facility.

Innomar Strategies' VP discusses early commercialization planning for specialty therapies in the Canadian market, highlighting regulatory, access, and reimbursement differences from the US.

A privacy breach at Innomar Strategies Inc., stemming from a Cencora data breach, affected thousands in Saskatchewan, compromising sensitive health information, leading to recommendations for extended credit monitoring.

Innomar Strategies Inc. experienced a privacy breach, impacting 7,293 people in Saskatchewan due to a ransomware attack on its parent company, Cencora.

Cencora, Inc. and its Canadian subsidiary, Innomar Strategies, Inc., face a class action lawsuit for a privacy breach that exposed the personal and health information of Canadian individuals.

A class action lawsuit was filed against Cencora, Inc. and Innomar Strategies, Inc. in Vancouver due to a privacy breach that compromised Canadians' sensitive health and personal information.

The Quebec pharmacists' association is pursuing a class-action lawsuit over patient steering to certain pharmacies for specialty medications by third-party companies and some of its members.

Innomar Strategies inaugurated a 92,000-square-foot third-party logistics center in Halton Hills, Ontario, for pharmaceutical and medical device storage, including complex specialty medications and those requiring specific temperature controls.

Sandra Anderson, Senior Vice-President at Innomar Strategies, leads the commercialization and strategy team, focusing on innovation and market access for specialty manufacturers in Canada.

Innomar Strategies acquired Cameron Stewart LifeScience, a provider of brand loyalty and patient financial assistance programs for the Canadian pharmaceutical industry, including the RxHelp.ca platform and RxHelp ONE HUBCAP trade card.

FedEx Express Canada and Innomar Strategies are collaborating to distribute the Moderna COVID-19 vaccine across Canada, including to remote northern regions, utilizing specialized cold-chain logistics and real-time monitoring.

FedEx and Innomar Strategies have begun distributing the first 168,000 doses of the Moderna COVID-19 vaccine across Canada.

FedEx Express Canada and Innomar Strategies have begun distributing the Moderna COVID-19 vaccine across Canada, utilizing specialized cold-chain logistics and real-time monitoring to ensure safe and timely delivery.

FedEx Express Canada and Innomar Strategies commenced the distribution of the Moderna COVID-19 vaccine across Canada, leveraging specialized cold-chain storage and real-time monitoring to ensure safe delivery.

FedEx Canada and Innomar Strategies secured a CA$90.4 million contract from the Canadian government to distribute COVID-19 vaccines.

Five firms, including Kuehne + Nagel and FedEx Canada jointly with Innomar Strategies, have been prequalified by the Canadian government to bid on a contract to distribute COVID-19 vaccines across Canada.

Telus Health, Canada Life, and Innomar Strategies are collaborating to introduce Canada's first electronic drug prior authorization solution.

TELUS Health, Canada Life, and Innomar Strategies are piloting Canada's first electronic prior authorization solution to streamline prescription medication approvals.